当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析

浙江医药

(600216)

  

流通市值:91.64亿  总市值:91.96亿
流通股本:9.62亿   总股本:9.65亿

浙江医药(600216)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.79亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益1006645.44万元,未分配利润514433.99万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产1290976.80万元,负债284331.36万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入2,249,164,467.27,794,145,971.375,876,518,447.273,937,942,897.55
营业总成本2,131,384,649.467,681,665,559.365,607,285,954.163,702,739,461.73
营业利润101,797,810.27380,158,265.1259,254,227.97252,816,649.35
利润总额101,044,464.45363,278,706.95268,382,586.93262,915,098.18
净利润79,363,327.86276,794,127.84180,865,708.32187,000,510.56
其他综合收益-3,950,569.5611,713,075.315,759,087.0913,968,045.4
综合收益总额75,412,758.3288,507,203.15186,624,795.41200,968,555.96
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计5,666,395,143.635,601,409,763.895,496,405,372.795,768,396,193.41
非流动资产合计7,243,372,866.697,178,129,992.327,096,460,449.686,952,233,585.07
资产总计12,909,768,010.3212,779,539,756.2112,592,865,822.4712,720,629,778.48
流动负债合计2,385,152,071.482,478,442,290.222,572,418,753.412,529,678,636.26
非流动负债合计458,161,540.82314,703,696.1121,117,263.31121,334,618.9
负债合计2,843,313,612.32,793,145,986.322,693,536,016.722,651,013,255.16
归属于母公司股东权益合计9,738,930,248.619,630,715,541.499,513,444,658.19,650,133,199.53
股东权益合计10,066,454,398.029,986,393,769.899,899,329,805.7510,069,616,523.32
负债和股东权益合计12,909,768,010.3212,779,539,756.2112,592,865,822.4712,720,629,778.48
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计2,052,836,052.368,235,518,301.556,332,953,973.344,234,690,025.04
经营活动现金流出小计2,029,665,501.167,601,207,138.215,922,250,858.393,982,234,257.71
经营活动产生的现金流量净额23,170,551.2634,311,163.34410,703,114.95252,455,767.33
投资活动现金流入小计470,624,455.761,268,760,630.361,073,692,177.04825,866,031.73
投资活动现金流出小计412,848,610.891,787,351,726.871,453,161,856.451,067,456,054.1
投资活动产生的现金流量净额57,775,844.87-518,591,096.51-379,469,679.41-241,590,022.37
筹资活动现金流入小计285,000,000655,055,038455,055,038355,055,038
筹资活动现金流出小计241,723,583.36796,484,821.59588,690,277.73317,911,115.57
筹资活动产生的现金流量净额43,276,416.64-141,429,783.59-133,635,239.7337,143,922.43
汇率变动对现金及现金等价物的影响44,689.5147,640,090.0414,044,955.1521,604,071.54
现金及现金等价物净增加额124,267,502.2221,930,373.28-88,356,849.0469,613,738.93
期末现金及现金等价物余额1,584,107,142.411,459,839,640.191,349,552,417.871,507,523,005.84
TOP↑